// App-Quantinova.ai

Mo2073 : X-LINKED INHIBITOR OF APOPTOSIS PROTEIN (XIAP) GENETIC VARIANTS IN PAEDIATRIC-ONSET IBD

Researchers

Presenter

  • A. Elkadri

Principal Investigators

  • N Warner

  • Shiqi Zhang

  • J Horowitz

  • Jeffrey Staples

  • John Overton

  • F Dewey

  • C Gonzaga-Jauregui

  • Anne M. Griffiths

  • Aleixo Muise

Medical Centers

  • Inflammatory Bowel Disease Center and Cell Biology Program, Research Institute,Hospital for Sick Children, Toronto, Toronto, Ontario, Canada

  • Medical College of Wisconsin, Milwaukee, Wisconsin , United States

  • Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children, Toronto, ON, Canada

Locations

  • United States

  • Canada

Companies

  • Regeneron Pharmaceut

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Nucleotide-binding oligomerization domain-containing protein 2

  • Tumor necrosis factor

  • X-linked inhibitor of apoptosis

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved